Quest Diagnostics Incorporated (DGX) CEO Steve Rusckowski on Q2 2020 Results - Earnings Call Transcript

Jul. 23, 2020 4:43 PM ETQuest Diagnostics Incorporated (DGX)1 Comment
SA Transcripts profile picture
SA Transcripts
133.68K Followers

Quest Diagnostics Incorporated (NYSE:DGX) Q2 2020 Results Conference Call July 23, 2020 8:30 AM ET

Company Participants

Shawn Bevec - Vice President of Investor Relations

Steve Rusckowski - Chairman, Chief Executive Officer & President

Mark Guinan - Chief Financial Officer

Conference Call Participants

Ann Hynes - Mizuho Securities

Stephen Baxter - Wolfe Research

Jack Meehan - Nephron Research

Ricky Goldwasser - Morgan Stanley

Ralph Giacobbe - Citi

Pito Chickering - Deutsche Bank

Kevin Caliendo - UBS

Lisa Gill - JPMorgan

Matt Larew - William Blair

Brian Tanquilut - Jefferies

Eric Coldwell - Robert W. Baird & Co.

Derik de Bruin - Bank of America

Mike Newshel - Evercore ISI

Operator

Welcome to the Quest Diagnostics Second Quarter 2020 Conference Call. At the request of the company, this call is being recorded. The entire contents of the call, including the presentation and question-and-answer session that will follow, are the copyrighted property of Quest Diagnostics with all rights reserved. Any redistribution, retransmission, or rebroadcast of this call in any form without the written consent of Quest Diagnostics is strictly prohibited.

Now, I'd like to introduce Shawn Bevec, Vice President of Investor Relations for Quest Diagnostics. Go ahead, please.

Shawn Bevec

Thank you, and good morning. I'm on the line with Steve Rusckowski, our Chairman, Chief Executive Officer, and President; and Mark Guinan, our Chief Financial Officer.

During this call, we may make forward-looking statements, and will discuss non-GAAP measures. We provide a reconciliation of non-GAAP measures to comparable GAAP measures in the tables to our earnings press release. Actual results may differ materially from those projected. Risks and uncertainties, including the impact of the COVID-19 pandemic that may affect Quest Diagnostics' future results, include but are not limited to, those described in our most recent Annual Report on Form 10-K, and subsequently filed quarterly reports on Form 10-Q, and current reports on Form

Recommended For You

Comments (1)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.